← Back to Clinical Trials
Recruiting NCT06349915

NCT06349915 A Pilot Evaluation of a Digital Peer Support Intervention for Suicidal Adolescents

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06349915
Status Recruiting
Phase
Sponsor Albert Einstein College of Medicine
Condition Suicide
Study Type INTERVENTIONAL
Enrollment 46 participants
Start Date 2026-04
Primary Completion 2027-10

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Supporting Wellbeing with Everyday Experiences of Peers (SWEEP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 46 participants in total. It began in 2026-04 with a primary completion date of 2027-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Suicide risk has increased among youth in underserved communities, where access to mental healthcare is limited. To address this need, the investigator team plans to evaluate the preliminary efficacy of a brief, low-cost, culturally responsive digital intervention for ethnically diverse youth at risk for suicide in The Bronx, New York. In collaboration with community stakeholders, suicide recovery narratives, featuring adolescents' experiences related to recovery from suicidal thoughts will be developed. A smartphone ecological momentary assessment (EMA) app will be used to evaluate whether a curriculum of these narratives provides anti-suicidal benefits to at-risk adolescents.

Eligibility Criteria

Inclusion Criteria: * past-month history of suicidal thoughts * past-month history of Major depressive disorder * possession of apple or android smartphone with data plan Exclusion Criteria: * inability to read/write in English * Active mania * Active psychosis * Autism spectrum disorder

Contact & Investigator

Central Contact

Peter J Franz, Ph.D.

✉ peter.franz@einsteinmed.edu

📞 6077278620

Principal Investigator

Peter J Franz, Ph.D.

PRINCIPAL INVESTIGATOR

Albert Einstein College of Medicine

Frequently Asked Questions

Who can join the NCT06349915 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 18 Years, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06349915 currently recruiting?

Yes, NCT06349915 is actively recruiting participants. Contact the research team at peter.franz@einsteinmed.edu for enrollment information.

Where is the NCT06349915 trial being conducted?

This trial is being conducted at The Bronx, United States.

Who is sponsoring the NCT06349915 clinical trial?

NCT06349915 is sponsored by Albert Einstein College of Medicine. The principal investigator is Peter J Franz, Ph.D. at Albert Einstein College of Medicine. The trial plans to enroll 46 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology